Navigation Links
bioMETRX, Inc. Completes Sequiam Asset Purchase
Date:7/8/2008

JERICHO, N.Y., July 8 /PRNewswire-FirstCall/ -- bioMETRX Inc., (OTC Bulletin Board: BMRX), today announced that it has closed the purchase of the assets of its former competitor, Sequiam Corporation. The company also announced that it has completed the integration of those assets into the company's technology portfolio and consumer based biometric products, several of which already are being sold under the company's smartTOUCH brand.

The purchase price paid for those assets is 44 Shares of Preferred Stock plus a maximum of 256 additional Shares of such Preferred Stock, subject to future conditions of vesting. 88 of the additional shares of Preferred Stock will vest on or before December 31, 2008, depending on the Company's ability to secure additional financing and the other 168 shares will vest on or before December 31, 2010, depending on the Company's aggregate revenues in the next 2.5 fiscal years. The Company's revenues must reach $15,000,000 over a 30-month timeframe for all of the Preferred Shares to be issued. The shares issued are restricted securities that are subject to additional leak-out provisions after the holding period expires. There is no convertible debt tied to this transaction. As part of this transaction, BIL will convert $250,000 of debt into the company's common stock.

"We are excited to acquire new technology, customers, and vendor relationships that will increase our ability to afford a broad range of consumer products. The addition of manufacturing in China, and securing Fujitsu as a new OEM account, has provided us powerful additional momentum. This transaction is part of our expansion through acquisition strategy of companies and products that will help accelerate company growth through revenue generation, as well as to compliment our already popular smartTOUCH product line of finger recognition consumer products," noted Mark R. Basile, CEO at bioMETRX.

As the global leader in consumer biometric product enginee
'/>"/>

SOURCE bioMETRX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology news :

1. bioMETRX, Inc. Gun Storage Products Endorsed by the Handgun Club of America
2. bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology
3. bioMETRX, Inc. Garage Door Opener Named Best In Class
4. bioMETRX, Inc. Files for Several New Patents
5. bioMETRX, Inc. Introduces New Products
6. bioMETRX, Inc. Closes Angel Round of Funding
7. bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line
8. bioMETRX, Inc. Acquires Patent for Biometric Padlock
9. bioMETRX, Inc. Acquires Patent for Biometric Padlock
10. bioMETRX, Inc. Calls Series B Warrants
11. Labwire Completes Its First Acquisition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e course of a lifetime, the heart pumps some 250 m...der to do this, the muscle fibers of the heart hav...ed by Dr. Wolfgang Rottbauer, vice chair of the De...Hospital (Chairman: Prof. Dr. H. A. Katus), has di...bility of the smallest muscular unit, the sarcomer...
(Date:11/24/2009)...us Research Institute (LRI) today named 12 new gra...million, recognize innovative work across a broad ...their creativity, novelty, and potential to drive ... and cure the complex disease of systemic lupus. ,...lupus researchers across the nation and include in...
(Date:11/24/2009)...mic-level action of a remarkable class of ring-sha...rs with the Lawrence Berkeley National Laboratory ...ystallography beamline at the Advanced Light Sourc...n gene expression and replication, and are vital t... infectious agents, such as the human papillomavir...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4NIMBioS hosts tutorial on optimal control and optimization for biologists 10071 1New Parkinsons Drug Draws Mixed Reviews 58192 1New Parkinsons Drug Draws Mixed Reviews 58192 2New Parkinsons Drug Draws Mixed Reviews 58192 3Minorities Less Likely to Have Blood Pressure Under Control 58190 1Minorities Less Likely to Have Blood Pressure Under Control 58190 2Minorities Less Likely to Have Blood Pressure Under Control 58190 3
...rchers at the University of Southern California (U...ed and expressed, may be the underlying cause for ...he Dec. 12 issue of Public Library of Science One....ge that a broad epigenetic defect is associated wi... M.D., MPH, professor of obstetrics and gynecology...
...s in Scandinavia have discovered that warm-water s...ce thrived in Danish waters during a prehistoric w...ies, such as cod, were also abundant during this p...rt. , Through the study of archaeological materia...s of monasteries, an international group of fisher...
...ogy partner on new aviation-re...er Holdings, Inc.,(OTC Bulletin Board: CTHH) ( htt...ntegrated mobile computing and Wi-Fi communication...ontechnology.com ), a leading,integrator of manage...ce a,major U.S. airline will be accepting delivery...
Other Biology News:USC researchers explore genetic causes for male infertility 2Ancient fish bones reveal impacts of global warming beneath the sea 2Ancient fish bones reveal impacts of global warming beneath the sea 3Ancient fish bones reveal impacts of global warming beneath the sea 4Ancient fish bones reveal impacts of global warming beneath the sea 5CATCHER to be Deployed at Major U.S. Airline 2CATCHER to be Deployed at Major U.S. Airline 3CATCHER to be Deployed at Major U.S. Airline 4
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novembe...c. (Nasdaq: DCGN ) today announced the approval of...ptcy Court for the District of Delaware,(the "Bank... petition for,relief under Chapter 11 of the Unite.... , The orders issued by the Bankruptcy C...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/...ood & Drug Administration (SFDA) has approved ... its oral insulin project,(Nodlin), an innovative ...proval allows Biolaxy to initiate its first phase ...r characteristic of high blood glucose and poor,me...
(Date:11/24/2009)... , , Primary efficacy endpoint has been met... endometrial cancer, , QUEBEC CITY, Nov. 24 /...DAQ: AEZS ; TSX: AEZ) (the "Company"), a global b...apy and oncology, today announced positive efficac...toxic peptide conjugate, AEZS-108 (formerly AN-152...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fir...RNA ) announced today that the company is schedu...alth Care Conference on December 1, 2009 at 11:30 ...New York Palace Hotel in New York City. Jack Lief,... scheduled to provide an overview of the company, ...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
... Integrated Global Services, CAMBRIDGE, Mass., Ap...launches under a new name, Abt Bio-Pharma Solution...es Inc. The company will continue to,provide custo...for the,pharmaceutical, biotechnology, medical dev...proach that blends decades of experience with wide...
...08 Cardium Therapeutics,(Amex: CXM ) and its ope...at,InnerCool has entered into a European commercia...Euromed), a leading distributor of cardiology,medi...romed will have,exclusive marketing, sales and dis...nd for InnerCool,s portfolio of temperature modula...
... 1, 2008 Derma Sciences,Inc (OTC Bulletin Board: ...reported that sales for 2007 were $34.1 million, a...ported for 2006. Gross margins held steady at 34,p... in new products for the,pipeline, and expanding t...ny reported a loss of $2.3 million or $0.09 loss p...
Other Biology Technology:Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc. 2Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 2Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 3Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 4Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 5Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 6Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 7Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 8Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems 9Derma Sciences Reports Fourth Quarter Year-End Results for 2007 2Derma Sciences Reports Fourth Quarter Year-End Results for 2007 3Derma Sciences Reports Fourth Quarter Year-End Results for 2007 4Derma Sciences Reports Fourth Quarter Year-End Results for 2007 5
Human Serum (All Male Donors) from Irvine Scientific
Human AB Serum from 3H Biomedical AB
Human HGF, Unconjugated from R&D Systems
Mouse MMP-9, Unconjugated from R&D Systems
Biology Products: